Actinium Pharmaceuticals EV - Enterprise Value 2011-2026 | ATNM

Annual EV - Enterprise Value Actinium Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
26.8 M	19.6 M	177 M	164 M	40.1 M	31.3 M	35 M	51.8 M	34.8 M	33.4 M	59.9 M	150 M	131 M	680 K	-5.62 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
177 M	-5.62 M	63.4 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Amgen AMGN	189 B	$ 349.36	2.75 %	$ 188 B	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Amneal Pharmaceuticals AMRX	4.03 B	$ 12.67	2.82 %	$ 3.97 B	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
argenx SE ARGX	-2.13 B	$ 784.45	2.48 %	$ 25 B	Niderland
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	3.64 B	$ 24.45	5.07 %	$ 3.11 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.47	8.17 %	$ 391 M	Britain
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.83	1.86 %	$ 9.21 B	Australia
BioNTech SE BNTX	-4.91 B	$ 91.3	1.87 %	$ 27.2 B	Germany
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	-15.2 M	$ 2.72	5.84 %	$ 17.1 M	USA
Burford Capital Limited BUR	3.22 B	$ 4.59	0.88 %	$ 742 M	Britain
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	9.99 M	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Cabaletta Bio CABA	253 M	$ 3.07	-	$ 308 M	USA
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.08	1.65 %	$ 6.7 B	Israel
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Cerus Corporation CERS	632 M	$ 1.93	4.89 %	$ 368 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	11.4 M	-	-	$ 231 M	USA
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	14.7 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	664 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	-2.16 M	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	-651 K	$ 2.82	2.55 %	$ 7.36 M	USA
Deciphera Pharmaceuticals DCPH	1.24 B	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	2.02 B	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Cyclerion Therapeutics CYCN	3.31 M	$ 3.47	-0.29 %	$ 8.74 M	USA